P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000972860.64685.8e |
| _version_ | 1797280002355494912 |
|---|---|
| author | P Harikrishnan Uday Yanamandra J Muthukrishnan Deeptika Aggarwal Arun Yadav Sk Singh Harshit Khurana Renjith Verghese |
| author_facet | P Harikrishnan Uday Yanamandra J Muthukrishnan Deeptika Aggarwal Arun Yadav Sk Singh Harshit Khurana Renjith Verghese |
| author_sort | P Harikrishnan |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:33:58Z |
| format | Article |
| id | doaj.art-e71708d1269a456e8d8c45f2f0613d41 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:33:58Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e71708d1269a456e8d8c45f2f0613d412024-03-03T10:04:28ZengWileyHemaSphere2572-92412023-08-017e646858e10.1097/01.HS9.0000972860.64685.8e202308003-01389P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIAP Harikrishnan0Uday Yanamandra1J Muthukrishnan2Deeptika Aggarwal3Arun Yadav4Sk Singh5Harshit Khurana6Renjith Verghese71 Armed Forces Medical College Pune, Pune, India1 Armed Forces Medical College Pune, Pune, India1 Armed Forces Medical College Pune, Pune, India1 Armed Forces Medical College Pune, Pune, India1 Armed Forces Medical College Pune, Pune, India1 Armed Forces Medical College Pune, Pune, India1 Armed Forces Medical College Pune, Pune, India2 Command Hospital (Southern Command), Pune, Indiahttp://journals.lww.com/10.1097/01.HS9.0000972860.64685.8e |
| spellingShingle | P Harikrishnan Uday Yanamandra J Muthukrishnan Deeptika Aggarwal Arun Yadav Sk Singh Harshit Khurana Renjith Verghese P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA HemaSphere |
| title | P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA |
| title_full | P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA |
| title_fullStr | P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA |
| title_full_unstemmed | P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA |
| title_short | P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA |
| title_sort | p1495 a phase iii randomised controlled safety efficacy and cost effectiveness trial of intravenous iron isomaltoside i3r and ferric carboxy maltose feriumr in subjects with iron deficiency anemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000972860.64685.8e |
| work_keys_str_mv | AT pharikrishnan p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT udayyanamandra p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT jmuthukrishnan p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT deeptikaaggarwal p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT arunyadav p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT sksingh p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT harshitkhurana p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia AT renjithverghese p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia |